SEARCH
We are still not taking buying call on Lupin, Cipla & Sun Pharma, says market guru SP Tulsian
CNBC-TV18
2019-11-06
Views
285
Description
Share / Embed
Download This Video
Report
SP Tulsian of sptulsian.com is a renowned market analyst, he provided his analysis on the fundamental side of the market as well as specific stocks and sectors in an interview with CNBC-TV18.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x7nmnjl" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
08:51
Here are some of the value buys according to market guru SP Tulsian
07:52
Will be wary of taking an investment call on DHFL at the current level, says stock analyst SP Tulsian
01:01
Buy Cipla, Lupin, Geometric, Ceat Mitesh Thacker
03:25
Stocks in news: Sun Pharma, Cipla, Hindalco
29:05
Lupin & Sun Pharma: Can Largecap Pharma Stocks Offer Better Immunity? #AskBQ
02:14
Cipla & Lupin Q3FY19 numbers: Key things to watch out for
01:53
Cipla to replace Sun Pharma in Sensex
02:17
Sensex Up By 145 Points, Sun Pharma, Cipla, Tata Motors Gain
13:16
Stocks In Focus: M&M, ACC, Cipla, Lupin, DRL and More
01:11
Buy Cipla, Sun Pharma, Sell Tata Steel : Ashwani Gujral
01:18
Hot stocks: Cipla, Sun Pharma, Tata Steel, Bajaj Auto, BoB
01:40
Cipla Acquires South Africa's Actor Pharma